Farms.com Home   News

H1N1 and H1N2 Viruses Represent Low Risk to People

The General Manger of Manitoba Pork says the identification of two rare strains of Influenza virus in humans in Manitoba poses a minimal risk to humans. On Friday Manitoba's Chief Public Health Officer and Chief Veterinary Officer confirmed two positive human cases, one of H1N1 and one of H1N2 virus and that the cases are unrelated.

Cam Dahl, the General Manager of Manitoba Pork, notes although these strains are reportable to the Public Health Agency of Canada and the World Health Organization, they represent a low-risk people.

Clip-Cam Dahl-Manitoba Pork:

These are variations of the Influenza A virus and these two strains in particular are really quite rare in people. The H1N2 variant, there's only been 29 cases in the world since we started monitoring in 2005 and the H1N1 variant that was found, there's only been two cases ever found in Canada.

These are two very rare strains of Influenza and there's very low risk as was announced by the CVO and the Chief Public Health Officer on Friday. There's very low risk of transmissibility between people.

In fact, we have no evidence of sustained transmissibility between people so there's very low risk to the public and fortunately the two people that did contract these strains of  the flu, their symptoms were very mild and they have both recovered so there's really very little risk to the Manitoba population.

Source : Farmscape

Trending Video

How Novonesis is Reshaping Swine Nutrition with Enzymes, Probiotics & Biological Solutions

Video: How Novonesis is Reshaping Swine Nutrition with Enzymes, Probiotics & Biological Solutions


The merger of Novozymes and Chr. Hansen created Novonesis, a global biosolutions leader combining more than a century of expertise in enzymes, probiotics and microbial science. In this exclusive interview, Keith Kinsley discusses how bringing these two industry innovators together is creating new opportunities for pork producers across North America and around the world.

Keith explains how Novonesis is leveraging the strengths of both legacy companies to deliver a more integrated approach to swine nutrition, gut health and feed efficiency. From sow productivity and piglet development to grow-finish performance, Novonesis offers science-backed biological solutions designed to help producers maximize feed utilization, support microbiome robustness and improve overall herd performance.